Skip to main content
. 2010 Dec;16(12):1976–1978. doi: 10.3201/eid1612.091697

Table 1. Results of screening of clinical samples from 23 US states for pandemic (H1N1) 2009 virus and bacterial respiratory targets, May–October 2009*.

No. (%) samples
Bacteria detected, no. (%) samples
S. aureus P. aeruginosa S. pyogenes N. meningitidis H. influenzae C. pneum K. pneum M. pneum S. pneum A. baumannii
Pandemic (H1N1) 2009 positive, 3,110 (29.270)
458 (14.727)
3
(0.096)
4
(0.129)
7
(0.225)
110 (3.537)
1 (0.032)
22 (0.707)
1 (0.032)
316 (10.161)
34
(1.093)
Pandemic (H1N1) 2009 negative, 7,514 (70.730)
875 (11.645)
28
(0.373)
34 (0.452)
16
(0.213)
411 (5.470)
8 (0.106)
44 (0.586)
8 (0.106)
573 (7.626)
152 (2.023)
Total, 10,624 (100.000) 1,333 (12.547) 31
(0.292) 38 (0.358) 23
(0.216) 521 (4.904) 9 (0.085) 66 (0.621) 9 (0.085) 889 (8.367) 186 (1.751)

*Screening for Legionella pneumophilia detected no bacteria in any samples. S. aureus, Staphylococcus aureus; P. aeruginosa, Pseudomonas aeruginosa; S. pyogenes, Streptococcus pyogenes; N. meningitidis, Neisseria meningitidis; H. influenzae, Haemophilus influenzae; C. pneum, Chlamydophila pneumoniae; K. pneum, Klebsiella pneumoniae; M. pneum, Mycoplasma pneumoniae; S. pneum, Streptococcus pneumoniae; A. baumannii, Acinetobacter baumannii. Boldface indicates predominant pathogens.